Journals / İzmir Göğüs Hastanesi Dergisi / 2021 / Cilt: 35 - Sayı: 2

The Effect of Lung Cancer and Chemotherapy on Sleep Quality and Quality of Life

Akciğer Kanserinin ve Kemoterapinin Uyku ve Yaşam KalitesiÜzerine Etkisi

Pages
82–90
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, while chemotherapy does not make a significant change in the sleep qualityof patients in the early period in patients with lung cancer, it may negatively affect the quality of life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Lung cancer affects the quality of sleep and life depending on both local and systemic impacts.Chemotherapy that is frequently used in the treatment of lung cancer can affect quality of sleep and life dueto disease response, side effects of chemotherapy, systemic effects due to chemotherapeutic agents andcomplications of immunosuppression.
📊
Key Findings & Data:Method: The Pittsburg Sleep Quality Index and the EORTC QLQ-C30 Cancer Patients’ Quality of Life Scalewere applied to the patients who received chemotherapy alone with diagnosis of locally advanced andmetastatic stage lung cancer at the time of diagnosis and after the third course of chemotherapy toevaluate sleep quality and quality of life.
💡
Conclusion & Impact:Conclusion: In conclusion, while chemotherapy does not make a significant change in the sleep qualityof patients in the early period in patients with lung cancer, it may negatively affect the quality of life.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Lung cancer affects the quality of sleep and life depending on both local and systemic impacts.Chemotherapy that is frequently used in the treatment of lung cancer can affect quality of sleep and life dueto disease response, side effects of chemotherapy, systemic effects due to chemotherapeutic agents andcomplications of immunosuppression. The sleep and life quality levels of patients with locally advanced andmetastatic stage lung cancer and the effect of chemotherapy on sleep and quality of life in this patient groupwere investigated in this study. Method: The Pittsburg Sleep Quality Index and the EORTC QLQ-C30 Cancer Patients’ Quality of Life Scalewere applied to the patients who received chemotherapy alone with diagnosis of locally advanced andmetastatic stage lung cancer at the time of diagnosis and after the third course of chemotherapy toevaluate sleep quality and quality of life. The mean age of the patients was 61.85 (± 6.80) and 89.8% ofthem were male. 69.5% of all patients had poor sleep quality at the time of diagnosis. Physical functionwas found to be affected the most in terms of functional parameters. The symptoms that most affectedthe quality of life were fatigue and dyspnea. Results: A significant correlation was observed between sleep quality and quality of life at the time ofdiagnosis in patients with lung cancer, but no significant change was found in sleep quality in the earlyperiod after chemotherapy. There was a statistically weak worsening in social functions and nauseasymptom after chemotherapy and a statistically significant worsening in the malaise symptom when thequality of life scores were evaluated. Other quality of life parameters were generally similar to thosebefore treatment. Conclusion: In conclusion, while chemotherapy does not make a significant change in the sleep qualityof patients in the early period in patients with lung cancer, it may negatively affect the quality of life.

Özet

Amaç: Akciğer kanseri, hem lokal hem de sistemik etkilerine bağlı olarak uyku ve yaşam kalitelerini etkilemektedir. Akciğer kanseri tedavisinde sıklıkla kullanılan kemoterapi ise; hastalık yanıtı, kemoterapi yan etkileri, kemoterapötik ajana bağlı sistemik etkiler ve immünsupresyon sonucu gelişen komplikasyonlar nedenleriyle uyku ve yaşam kalitelerini etkileyebilmektedir. Bu çalışmada, lokal ileri ve metastatik evre akciğer kanserli hastalarda, kemoterapinin erken dönemde uyku ve yaşam kaliteleri üzerine etkisi araştırıldı.Yöntem: Lokal ileri ve metastatik evre akciğer kanseri tanısı ile tek başına kemoterapi alan hastalara tanı anında ve 3. kür kemoterapi sonrası uyku kalitesi ve yaşam kalitesini değerlendirebilmek için Pittsburg Uyku Kalitesi İndeksi ve EORTC QLQ-C30 Kanser Hastalarının Yaşam Kalitesi Ölçeği uygulandı. Hastaların ortalama yaşı 61.85’ti (±6.80) ve %89.8’i erkekti. Tanı anında hastaların %69,5’i kötü uyku kalitesine sahipti. Fonksiyonel parametreler açısından en çok fiziksel işlev etkilenmiş olarak saptandı. Yaşam kalitesini en çok etkileyen semptomlar hâlsizlik ve dispneydi.Bulgular: Akciğer kanserli hastalarda tanı sırasında uyku ve yaşam kaliteleri arasında belirgin korelasyon gözlendi, ancak kemoterapi sonrası erken dönemde uyku kalitesinde anlamlı değişiklik saptanmadı. Yaşam kalitesi skorları değerlendirildiğinde kemoterapi sonrası sosyal işlevlerde ve bulantı semptomunda istatistiksel olarak zayıf; hâlsizlik semptomunda istatistiksel olarak belirgin kötüleşme vardı. Diğer yaşam kalitesi parametreleri genel olarak tedavi öncesi ile benzerdi.Sonuç: Sonuç olarak, akciğer kanserli hastalarda kemoterapi erken dönemde hastaların uyku kalitesinde belirgin bir değişiklik yapmıyorken yaşam kalitesini olumsuz yönde etkileyebilmektedir.

🔖

Cite This Article

GÖKTALAY, T., HAVLUCU, Y., KIZILIRMAK, D., ÇELİK, P., GÜLTEKİN, Ö. (2022). The Effect of Lung Cancer and Chemotherapy on Sleep Quality and Quality of Life. İzmir Göğüs Hastanesi Dergisi, Cilt: 35 - Sayı: 2, 82–90. https://ajindex.com/articles/557825

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Yavuzşen T, Alacacıoğlu A, Çeltik A, Yılmaz U. Kanser ve uyku bozuklukları. Türk Onkoloji Dergisi 2014;29(3): 112-9
  2. Göktalay T, Akın M, Aydemir Ö. Akciğer kanserli hastalarda yaşam kalitesi değerlendirilmesi. Solunum Hastalıkları 2002;13:265-70
  3. Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. OncoTargets and Therapy 2016;9:1023-8.
  4. Daroszewski C, Stasiewicz M, Jazwinska-Tarnawska E, Rachwalik A, Mura E, Luboch-Kowal J, et al. Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy. Advances in Experimental Medicine and Biology 2019;1160:11-8.
  5. Brierley JD, Gospodarowicz MK, Wittekind C eds. TNM Classification of Malignant Tumours, 8th Edition. International Union Against Cancer (UICC). WileyBlackwell; 2017. https://doi.org/10.1002/9780471420194.tnmc26. pub3 6. Buysse D, Reynolds C, Monk T, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality İndex: A New İnstrument For Psychiatric Practice And Research. Psychiatry Research 1989;28(2):193-213.
  6. Ağargün MY, Kara H, Anlar Ö. Pittsburgh Uyku Kalitesi İndeksi’nin Geçerliği ve Güvenirliği. Türk Psikiyatri Dergisi 1996;7(2)
  7. Bergman, B., Aeronson, N., Ahmedzai, SH., Kaasa, S., and Sullivan, M. The EORTC QLQ-LC13: A Modular Supplement to The EORTC Core Quality of Life Questionnaire (QLQ-C30) for Use in Lung Cancer Trials. EORTC Study Group on Quality of Life. Eur J. Cancer 1994;30A(5) 635-42.
  8. Güzelant A, Göksel T, Ozkok S, Aysan T, Bottomley A. The European organization for research and treatment of cancer QLQ C-30: An Examination into the culturel validity and reliability of Turkish version Of QLQ-C-30. European Journal Of Cancer Care 2004;13(2):135-44.
  9. Eser S, Göksel T, Erbaycu AE, Baydur H, Başarık B, Öz Yanık A, Kıyar Gürsul K, et al. Comparison of generic and lung cancer specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer. Springer Plus 2016;5:1833.
  10. Moens KJ. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. Pain Symptom Manage 2014